L. L. Van De Verg

发表

Deletion of purE attenuates Brucella melitensis infection in mice

T. Hadfield, R. Crawford, D. Hoover, 1996, Infection and immunity.

Bacteriologic and histologic features in mice after intranasal inoculation of Brucella melitensis.

T. Hadfield, D. Hoover, L. Lindler, 2001, American journal of veterinary research.

Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis

T. Hadfield, D. Hoover, L. Lindler, 1996, Infection and immunity.

Native and Mutant Forms of Cholera Toxin and Heat-Labile Enterotoxin Effectively Enhance Protective Efficacy of Live Attenuated and Heat-Killed Shigella Vaccines

M. Venkatesan, L. L. Van De Verg, A. Hartman, 1999, Infection and Immunity.

Development and Preclinical Evaluation of a Trivalent, Formalin-Inactivated Shigella Whole-Cell Vaccine

A. L. Bourgeois, R. Walker, L. L. Van De Verg, 2014, Clinical and Vaccine Immunology.

Safety and immunogenicity of an oral, inactivated, whole-cell vaccine for Shigella sonnei: preclinical studies and a Phase I trial.

A. L. Bourgeois, R. Walker, R. Mckenzie, 2006, Vaccine.

Vaccines for enteric diseases: a meeting summary

M. Riddle, L. L. Van De Verg, D. Steele, 2012, Expert review of vaccines.

Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations.

M. Levine, D. Herrington, A. Lindberg, 1992, The Journal of infectious diseases.

Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei

M. Levine, D. Herrington, J. Murphy, 1990, Infection and immunity.

Cross-reactivity of Shigella flexneri serotype 2a O antigen antibodies following immunization or infection.

D. N. Taylor, K. Kotloff, L. L. Van De Verg, 1996, Vaccine.

Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects

D. Sack, S. Chakraborty, L. Dally, 2016, Clinical and Vaccine Immunology.

Editorial commentary: a Shigella vaccine against prevalent serotypes.

M. Venkatesan, L. L. Van De Verg, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.

M. Levine, S. Cryz, D. Herrington, 1990, Vaccine.

Outer membrane protein of Neisseria meningitidis as a mucosal adjuvant for lipopolysaccharide of Brucella melitensis in mouse and guinea pig intranasal immunization models

T. Hadfield, D. Hoover, B. Tall, 1996, Infection and immunity.

Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen

M. Levine, D. Herrington, J. Sadoff, 1992, Infection and immunity.

Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli

S. El-Kamary, Wilbur H. Chen, Mitchell Cohen, 2013, Clinical and Vaccine Immunology.

Protection of Mice against Brucellosis by Vaccination with Brucella melitensisWR201(16MΔpurEK)

T. Hadfield, R. Crawford, D. Hoover, 1999, Infection and Immunity.

Specificity of monoclonal antibodies elicited by mucosal infection of BALB/c mice with virulent Shigella flexneri 2a

S. Smith‐Gill, B. Tall, L. L. Van De Verg, 1996, Clinical and diagnostic laboratory immunology.

Protection of Mice against Brucellosis by Intranasal Immunization with Brucella melitensis Lipopolysaccharide as a Noncovalent Complex with Neisseria meningitidis Group B Outer Membrane Protein

T. Hadfield, D. Hoover, A. Bhattacharjee, 2002, Infection and Immunity.

Sialylation lessens the infectivity of Neisseria gonorrhoeae MS11mkC.

A. Cross, J. Sadoff, R. Warren, 1996, The Journal of infectious diseases.

Combination vaccines against diarrheal diseases

M. Venkatesan, L. L. Van De Verg, 2015, Human vaccines & immunotherapeutics.

A study of different buffers to maximize viability of an oral Shigella vaccine.

M. Lal, M. Venkatesan, L. L. Van De Verg, 2015, Vaccine.

Characterization of a Novel Fusion Protein from IpaB and IpaD of Shigella spp. and Its Potential as a Pan-Shigella Vaccine

W. Picking, J. Clements, N. Dickenson, 2013, Infection and Immunity.

Intradermal Delivery of Shigella IpaB and IpaD Type III Secretion Proteins: Kinetics of Cell Recruitment and Antigen Uptake, Mucosal and Systemic Immunity, and Protection across Serotypes

C. Drachenberg, A. Andar, W. Picking, 2014, The Journal of Immunology.

Outpatient studies of the safety and immunogenicity of an auxotrophic Escherichia coli K-12-Shigella flexneri 2a hybrid vaccine candidate, EcSf2a-2.

D. N. Taylor, J. Sadoff, L. L. Van De Verg, 1994, Vaccine.

Experimental Gonococcal Urethritis and Reinfection with Homologous Gonococci in Male Volunteers

C. Deal, J. McClain, J. Griffiss, 2001, Sexually transmitted diseases.

Enteric vaccines for pediatric use. Workshop summary.

Robert H. Hall, Katherine Woo, R. Walker, 2005, Vaccine.

Antibody and cytokine responses in a mouse pulmonary model of Shigella flexneri serotype 2a infection

H. Collins, T. Larsen, L. L. Van De Verg, 1995, Infection and immunity.

Local immune response and protection in the guinea pig keratoconjunctivitis model following immunization with Shigella vaccines

D. N. Taylor, H. Collins, L. L. Van De Verg, 1994, Infection and immunity.

Characteristics of Shigella sonnei infection of volunteers: signs, symptoms, immune responses, changes in selected cytokines and acute-phase substances.

J. Olson, D. N. Taylor, S. Goldblum, 1995, The American journal of tropical medicine and hygiene.

Safety and Immunogenicity of a Single Oral Dose of Recombinant Double Mutant Heat-Labile Toxin Derived from Enterotoxigenic Escherichia coli

S. El-Kamary, Wilbur H. Chen, Mitchell Cohen, 2014, Clinical and Vaccine Immunology.